呼吸道疾病在儿科领域中仍为我国现阶段的常见病、多发病,是世界各国重视的课题,而且有一定的病死率,值得儿科工作者在现有的基础上采用新概念、新技术、新诊断方法和新的药物,来提高小儿呼吸系统疾病的临床诊断治疗水平。由深圳制药厂研制成功的美欧卡霉素(Miocamycin;MoM)干糖浆的推出,对 Respiratory diseases in the field of pediatrics is still common in our country at this stage, frequently-occurring disease, is the focus of all countries in the world, but also a certain fatality rate, it is worth pediatric workers on the basis of the existing new concepts, new technologies, new Diagnostic methods and new drugs to improve the clinical diagnosis and treatment of respiratory diseases in children. The introduction of the Miocamycin (MoM) dry syrup, which was successfully developed by Shenzhen Pharmaceutical Factory,